Filing Details
- Accession Number:
- 0001209191-16-138310
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-23 16:28:22
- Reporting Period:
- 2016-08-19
- Filing Date:
- 2016-08-23
- Accepted Time:
- 2016-08-23 16:28:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591950 | Maher Albitar | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-08-19 | 200,000 | $1.43 | 263,492 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2016-08-19 | 20,000 | $3.45 | 283,492 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2016-08-19 | 100,000 | $4.78 | 383,492 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2016-08-19 | 250,000 | $1.43 | 633,492 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-08-19 | 370,000 | $8.23 | 263,492 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-08-19 | 34,625 | $8.26 | 228,867 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants (Right to Buy) | Disposition | 2016-08-19 | 200,000 | $1.43 | 200,000 | $1.43 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2016-08-19 | 20,000 | $3.45 | 20,000 | $3.45 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2016-08-19 | 100,000 | $4.78 | 100,000 | $4.78 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2016-08-19 | 250,000 | $1.43 | 250,000 | $1.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-05-09 | 2017-01-09 | No | 4 | X | Direct |
10,000 | 2015-03-05 | 2019-03-05 | No | 4 | X | Direct |
200,000 | 2016-05-05 | 2020-05-05 | No | 4 | X | Direct |
0 | 2013-01-09 | 2017-01-09 | No | 4 | X | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 63,492 | Indirect | Shares owned by Albitar Oncology Defined Benefit Plan |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $7.15 | 2017-04-20 | 2021-04-20 | 200,000 | 200,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-04-20 | 200,000 | 200,000 | Direct |
Footnotes
- Shares withheld by NeoGenomics, Inc. to satisfy the cost of shares in connection with the August 19, 2016 warrant exercise.
- Closing stock price on date of exercise, August 19, 2016.
- These warrants were issued to Dr. Albitar upon the start of his service to the Company and vest upon the achievement of certain milestones.
- On March 5, 2014 Dr. Albitar was granted 30,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- On May 5, 2015 Dr. Albitar was granted 300,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- These stock options were granted upon the start of Dr. Albitar's service to the Company and vest ratably over each of his first four anniversaries with the Company.
- On April 20, 2016, Dr. Albitar was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.